Adenocarcinoma (Esophageal)
Overview and clinical definition are open. Full Step 1 details unlock with a plan.
For the why behind the fact
Use this page to connect what you are memorizing.
Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.
Overview
Plain-Language Overview
Esophageal adenocarcinoma is a cancer of gland-forming cells, usually in the lower part of the esophagus, the tube carrying food to the stomach. Long-term reflux, obesity and smoking increase risk. It can develop through Barrett esophagus, a change in the lining, but most people with Barrett esophagus do not develop cancer and many patients with cancer had no prior Barrett diagnosis. Early disease may cause no symptoms. Progressive trouble swallowing and unexplained weight loss need prompt evaluation; diagnosis requires endoscopy with a tissue sample. Treatment depends on how deeply the cancer has grown and whether it has spread.
Clinical Definition
Esophageal adenocarcinoma is an invasive malignant epithelial tumor with glandular differentiation, often with mucin production, usually arising in the distal esophagus. The classic sequence is reflux-associated Barrett intestinal metaplasia → dysplasia → invasive adenocarcinoma; metaplasia itself is not cancer and progression is not inevitable. Barrett mucosa contains specialized columnar epithelium with goblet cells, replacing normal stratified squamous lining. Alterations of tumor suppressors such as TP53/CDKN2A and oncogenic amplification such as ERBB2 (HER2) occur during neoplastic evolution, but no single molecular alteration is required for diagnosis. Progressive dysphagia and weight loss are alarm features. Histology establishes the diagnosis; depth, nodal involvement, distant spread and relevant biomarkers guide management.